• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.47 Down 0.02(3.09%) May 22, 4:03PM EDT
    Add to Portfolio
    Prev Close:0.49
    Open:0.48
    Bid:0.47 x 10000
    Ask:0.58 x 1000
    1y Target Est:3.00
    Beta:0.44
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:0.47 - 0.50
    52wk Range:0.43 - 1.45
    Volume:317,060
    Avg Vol (3m):871,178
    Market Cap:42.42M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 3.09%42.42M
    AGENUp 5.73%501.11M
    DNDN 0.00%N/A
    STMLDown 1.51%233.69M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.18
    Quarterly EPS Est (Jun-15) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback